Jan 11, 2022 / 01:15PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. Welcome to day 2 of the healthcare conference. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce our next company this morning, Thermo Fisher Scientific.
Just a quick reminder, if you have questions, you can send it in through the website.
And with that, I'll turn it over to Marc.
Marc N. Casper - Thermo Fisher Scientific Inc. - Chairman, President & CEO
Tycho, good morning. Nice to be with you at the Healthcare Conference to kick off 2022.
What I thought today is before we get to the Q&A session, I split the presentation into 2 parts. I would reorient everybody on Thermo Fisher Scientific and cover some of the key points about the company, our strategy, our performance. And then talk about how we did in 2021 qualitatively as well as our goal for 2022 in terms of some of the non-financial goals that we have, which has really been the approach that we've taken over many years at the JPMorgan
Thermo Fisher Scientific Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers